Sign in or Register   Sign in or Register
  |  

Mouse Anti-CHRNA5 Recombinant Antibody (7D3) (CBMAB-C8625-LY)

This product is antibody recognizes CHRNA5. The antibody 7D3 immunoassay techniques such as: ELISA, WB.
See all CHRNA5 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
7D3
Antibody Isotype
IgG1, κ
Application
ELISA, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG1, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
Cholinergic Receptor Nicotinic Alpha 5 Subunit
Introduction
The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010]
Entrez Gene ID
1138
UniProt ID
P30532
Alternative Names
Cholinergic Receptor Nicotinic Alpha 5 Subunit; Acetylcholine Receptor, Nicotinic, Alpha 5 (Neuronal); Cholinergic Receptor, Nicotinic, Alpha 5 (Neuronal); Cholinergic Receptor, Nicotinic Alpha 5; Cholinergic Receptor, Neuronal Nicotinic, Alpha Polypeptid
Function
After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
Biological Process
Behavioral response to nicotine Source: UniProtKB
Chemical synaptic transmission Source: GO_Central
Ion transmembrane transport Source: GO_Central
Nervous system process Source: GO_Central
Regulation of membrane potential Source: GO_Central
Regulation of synaptic vesicle exocytosis Source: Ensembl
Response to nicotine Source: GO_Central
Signal transduction Source: GO_Central
Synaptic transmission, cholinergic Source: GO_Central
Cellular Location
Postsynaptic cell membrane; Cell membrane
Topology
Extracellular: 23-254
Helical: 255-275
Helical: 282-302
Helical: 317-337
Cytoplasmic: 338-429
Helical: 430-451
Extracellular: 452-468

Forget, B., Icick, R., Robert, J., Correia, C., Prevost, M. S., Gielen, M., ... & Maskos, U. (2021). Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients. Progress in Neurobiology, 197, 101898.

Brynildsen, J. K., & Blendy, J. A. (2021). Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms. Neuropharmacology, 186, 108480.

Chen, L. S., Baker, T. B., Miller, J. P., Bray, M., Smock, N., Chen, J., ... & Bierut, L. J. (2020). Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a randomized placebo‐controlled trial. Clinical Pharmacology & Therapeutics, 108(6), 1315-1325.

Venkatesan, S., & Lambe, E. K. (2020). Chrna5 is essential for a rapid and protected response to optogenetic release of endogenous acetylcholine in prefrontal cortex. Journal of Neuroscience, 40(38), 7255-7268.

Tam, A., Obeidat, M., Hackett, T. L., Dorscheid, D. R., Singhera, G., Hogg, J. C., & Sin, D. D. (2019). Cholinergic Receptor Nicotinic Alpha 5 Expression in the Airways of Patients with Chronic Obstructive Pulmonary Disease. In B64. COPD: MECHANISM AND TREATMENT (pp. A3845-A3845). American Thoracic Society.

Lin, C. H., Lee, H. H., Kuei, C. H., Lin, H. Y., Lu, L. S., Lee, F. P., ... & Lin, Y. F. (2019). Nicotinic acetylcholine receptor subunit Alpha-5 promotes radioresistance via recruiting E2F activity in oral squamous cell carcinoma. Journal of clinical medicine, 8(9), 1454.

Tomaz, P. R. X., Santos, J. R., Scholz, J., Abe, T. O., Gaya, P. V., Negrão, A. B., ... & Santos, P. C. J. L. (2018). Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. BMC medical genetics, 19(1), 1-8.

Cingir Koker, S., Jahja, E., Shehwana, H., Keskus, A. G., & Konu, O. (2018). Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer. PloS one, 13(12), e0208982.

Köker, Ş. C. (2018). Effects of Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi on apoptosis, DNA damage response, drug sensitivity, and HSA-MIR-495-3P overexpression in breast cancer (Doctoral dissertation, Bilkent University).

Morton, G., Nasirova, N., Sparks, D. W., Brodsky, M., Sivakumaran, S., Lambe, E. K., & Turner, E. E. (2018). Chrna5-expressing neurons in the interpeduncular nucleus mediate aversion primed by prior stimulation or nicotine exposure. Journal of Neuroscience, 38(31), 6900-6920.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-CHRNA5 Recombinant Antibody (7D3)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare